Amedisys Reports First Quarter 2022 Financial Results and Reaffirms 2022 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys Reports First Quarter 2022 Financial Results and Reaffirms 2022 Guidance

Amedisys (AMED) Tops Q1 EPS by 11c; Offers FY22 Guidance

April 27, 2022 4:10 PM EDT

Amedisys (NASDAQ: AMED) reported Q1 EPS of $1.23, $0.11 better than the analyst estimate of $1.12. Revenue for the quarter came in at $545.3 million versus the consensus estimate of $558.84 million.

GUIDANCE:

Amedisys sees FY2022 EPS of $5.23-$5.45, versus the consensus of $5.33. Amedisys sees... More